These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 18071858)

  • 1. Brachytherapy with permanent seed implantation.
    Saito S; Nagata H; Kosugi M; Toya K; Yorozu A
    Int J Clin Oncol; 2007 Dec; 12(6):395-407. PubMed ID: 18071858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nationwide Japanese Prostate Cancer Outcome Study of Permanent Iodine-125 Seed Implantation (J-POPS).
    Saito S; Ito K; Yorozu A; Aoki M; Koga H; Satoh T; Ohashi T; Shigematsu N; Maruo S; Kikuchi T; Kojima S; Dokiya T; Fukushima M; Yamanaka H
    Int J Clin Oncol; 2015 Apr; 20(2):375-85. PubMed ID: 24840041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-reported health-related quality of life up to three years after the treatment with permanent brachytherapy: Outcome of the large-scale, prospective longitudinal study in Japanese-Prostate Cancer Outcome Study by Permanent I-125 Seed Implantation (J-POPS).
    Koga H; Naito S; Ishiyama H; Yorozu A; Saito S; Kojima S; Higashide S; Kikuchi T; Nakamura K; Dokiya T; Fukushima M;
    Brachytherapy; 2019; 18(6):806-813. PubMed ID: 31378511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of sexual function in Japanese men with prostate cancer undergoing permanent brachytherapy without androgen deprivation therapy: Analysis from the Japanese Prostate Cancer Outcome Study of Permanent Iodine-125 Seed Implantation database.
    Okihara K; Yorozu A; Saito S; Tanaka N; Koga H; Higashide S; Kikuchi T; Nakano M
    Int J Urol; 2017 Jul; 24(7):518-524. PubMed ID: 28455847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interstitial brachytherapy with permanent seed implants in early prostate cancer.
    Maurer U; Wiegel T; Hinkelbein W; Eble MJ
    Front Radiat Ther Oncol; 2002; 36():166-70. PubMed ID: 11842748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Four-year experience of interstitial permanent brachytherapy for Japanese men with localized prostate cancer.
    Ishiyama H; Satoh T; Kitano M; Tsumura H; Kotani S; Okusa H; Uemae M; Baba S; Hayakawa K
    Jpn J Clin Oncol; 2008 Jul; 38(7):469-73. PubMed ID: 18577509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Techniques, indications and results of permanent prostate brachytherapy for localized prostate cancer].
    Bladou F; Thuret R; Gravis G; Karsenty G; Serment G; Salem N
    Ann Urol (Paris); 2007 Apr; 41(2):68-79. PubMed ID: 17486914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does brachytherapy have a role in the treatment of prostate cancer?
    Grimm PD; Blasko JC; Ragde H; Sylvester J; Clarke D
    Hematol Oncol Clin North Am; 1996 Jun; 10(3):653-73. PubMed ID: 8773503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between percent positive biopsies and biochemical outcome after permanent interstitial brachytherapy for clinically organ-confined carcinoma of the prostate gland.
    Merrick GS; Butler WM; Galbreath RW; Lief JH; Adamovich E
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):664-73. PubMed ID: 11849788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iodine-125 seed implantation (permanent brachytherapy) for clinically localized prostate cancer.
    Ebara S; Katayama N; Tanimoto R; Edamura K; Nose H; Manabe D; Kobayashi T; Kobayashi Y; Kobuke M; Takemoto M; Saika T; Nasu Y; Kanazawa S; Kumon H
    Acta Med Okayama; 2008 Feb; 62(1):9-13. PubMed ID: 18323866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genitourinary toxicity after permanent iodine-125 seed implantation: The nationwide Japanese prostate cancer outcome study of permanent iodine-125 seed implantation (J-POPS).
    Tanaka N; Yorozu A; Kikuchi T; Higashide S; Kojima S; Ohashi T; Katayama N; Nakamura K; Saito S; Dokiya T; Fukushima M;
    Brachytherapy; 2019; 18(4):484-492. PubMed ID: 31072729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Permanent prostate brachytherapy for Japanese men: results from initial 100 patients with prostate cancer.
    Okaneya T; Nishizawa S; Nakayama T; Kamigaito T; Hashida I; Hosaka N
    Int J Urol; 2007 Jul; 14(7):602-6. PubMed ID: 17645602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Technical Report: Quality Assurance for
    Kojima T; Kawamura S; Otani Y; Yamada T; Okamoto H; Kamomae T; Yamashita O; Ooshita T; Kurosawa T; Wakitani Y; Hanada T; Yorozu A; Naniwa K; Moto T; Hasegawa G; Furuhata Y; Fujii K
    Igaku Butsuri; 2023; 43(1):1-16. PubMed ID: 37045758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [(125)I versus (103)Pd brachytherapy for low risk prostate cancer: a systematic review].
    Zhang LL; Ma L; Tian JH; Ren YY; Yang KH
    Ai Zheng; 2009 Aug; 28(8):872-8. PubMed ID: 19664336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seed migration after transperineal interstitial prostate brachytherapy by using loose seeds: Japanese prostate cancer outcome study of permanent iodine-125 seed implantation (J-POPS) multi-institutional cohort study.
    Nakano M; Yorozu A; Saito S; Sugawara A; Maruo S; Kojima S; Kikuchi T; Fukushima M; Dokiya T; Yamanaka H
    Radiat Oncol; 2015 Nov; 10():228. PubMed ID: 26577301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation.
    Zelefsky MJ; Kuban DA; Levy LB; Potters L; Beyer DC; Blasko JC; Moran BJ; Ciezki JP; Zietman AL; Pisansky TM; Elshaikh M; Horwitz EM
    Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):327-33. PubMed ID: 17084558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distant metastases following permanent interstitial brachytherapy for patients with clinically localized prostate cancer.
    Taira AV; Merrick GS; Galbreath RW; Butler WM; Lief J; Adamovich E; Wallner KE
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e225-32. PubMed ID: 21664066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Application of neoadjuvant hormonal therapy in (125)I permanent seed implantation for prostate cancer].
    Cui X; Li Q; Xu JJ; Li J; Ou TW
    Zhonghua Yi Xue Za Zhi; 2012 Oct; 92(38):2710-2. PubMed ID: 23290112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iodine-125 brachytherapy for localized prostate cancer and urinary morbidity: a prospective comparison of two seed implant methods-preplanning and intraoperative planning.
    Matzkin H; Kaver I; Stenger A; Agai R; Esna N; Chen J
    Urology; 2003 Sep; 62(3):497-502. PubMed ID: 12946754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncological impact of neoadjuvant hormonal therapy on permanent iodine-125 seed brachytherapy in patients with low- and intermediate-risk prostate cancer.
    Takamoto A; Tanimoto R; Bekku K; Araki M; Sadahira T; Wada K; Ebara S; Katayama N; Yanai H; Nasu Y
    Int J Urol; 2018 May; 25(5):507-512. PubMed ID: 29651796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.